Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Long non-coding RNA tumor suppressor candidate 7 (TUSC7) is a known tumor suppressor in various cancers.
• The specific role of TUSC7 in hepatocellular carcinoma (HCC) has not been previously elucidated.

Purpose of the Study:

• To investigate the function and mechanism of TUSC7 in hepatocellular carcinoma (HCC).
• To determine if TUSC7 can serve as a prognostic biomarker or therapeutic target for HCC.

Main Methods:

• Quantitative real-time PCR to assess TUSC7 expression in HCC tissues and cell lines.
• Bioinformatic analysis and luciferase reporter assays to confirm the interaction between TUSC7, miR-10a, and EphA4.
• Cell-based assays to evaluate the effects of TUSC7 on cell migration, invasion, and epithelial-to-mesenchymal transition (EMT).

Main Results:

• TUSC7 expression was significantly downregulated in HCC tissues compared to normal tissues.
• Lower TUSC7 expression was associated with poorer patient survival and identified as an independent risk factor for HCC.
• TUSC7 suppressed HCC cell metastasis, invasion, and EMT by competitively binding to miR-10a.
• TUSC7 downregulated Eph tyrosine kinase receptor A4 (EphA4) expression via the TUSC7-miR-10a-EphA4 axis.

Conclusions:

• TUSC7 functions as a tumor suppressor in HCC by inhibiting EMT through the TUSC7-miR-10a-EphA4 pathway.
• TUSC7 holds potential as a prognostic biomarker and therapeutic target for hepatocellular carcinoma.